B6.129-Wnt11tm1Amc/Oulu

Status

Available to order

EMMA IDEM:11255
International strain nameB6.129-Wnt11tm1Amc/Oulu
Alternative nameWnt11 knock-out
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolWnt11tm1Amc,
Gene/Transgene symbolWnt11

Information from provider

ProviderSeppo Vainio
Provider affiliationFaculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu
Additional ownerAndrew McMahon, University of Southern California, US
Genetic informationThe gene was disrupted by replacement of exons 4 and 5 with a PGK-neo cassette via homologous recombination. RT-PCR analysis of RNA from homozygous mutant animals revealed a truncated transcription product predicted to encode 28 N-terminal amino acids. This mutant protein is expected to be non-functional.
Phenotypic informationHomozygous:
Mortality/aging: The presence of the Wnt11 null allele in the C57BL/6 background partially overcomes the in utero lethality reported in the SV129 background. 1/3 of the Wnt11-/- mice with this inbred background survives to postnatal stages. Many of them also reach adulthood. The number of the surviving Wnt11-/- mice drops by around 50% by the age of 4–6 weeks. An additional reduction of 10% takes place by the age of 12 months. The proportion of female to male C57BL/6 Wnt11-/- survivors remains unchanged. Renal/urinary system: Hypoplastic kidneys. Glomerular cysts. Reduced amount of glomeruli. Compromised kidney function.

Heterozygous:
Mice heterozygous for this targeted mutation are viable and fertile with normal kidney size and histology.
Breeding historyA targeting vector was designed to replace exons 4 and 5 of the endogenous gene with a PGK-neo cassette. This construct was microinjected into (129X1/SvJ x 129S1/Sv)F1-derived R1 embryonic stem (ES) cells. Correctly targeted ES cells were injected into blastocysts. Chimeric mice were bred to "129 substrain AV3" inbred mice (129X1/SvJ). Heterozygous mice were maintained and expanded on this same genetic background (129X1/SvJ) prior to crossing to C57BL/6JOlaHsd and from 2014 to C57BL/6N (5 generations). Totally over 10 generations in C57 background.
References
  • Impairment of Wnt11 function leads to kidney tubular abnormalities and secondary glomerular cystogenesis.;Nagy Irina I, Xu Qi, Naillat Florence, Ali Nsrein, Miinalainen Ilkka, Samoylenko Anatoly, Vainio Seppo J, ;2016;BMC developmental biology;16;30; 27582005
  • Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric branching during metanephric kidney development.;Majumdar Arindam, Vainio Seppo, Kispert Andreas, McMahon Jill, McMahon Andrew P, ;2003;Development (Cambridge, England);130;3175-85; 12783789
Homozygous fertilenot known
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreUniversity of Oulu, Oulu, Finland
Animals used for archivingheterozygous C57BL/6NCrl

Disease and phenotype information

MGI phenotypes (allele matching)
  • delayed kidney development / MGI
  • small kidney / MGI
  • renal hypoplasia / MGI
  • decreased renal glomerulus number / MGI
  • impaired branching involved in ureteric bud morphogenesis / MGI
  • neonatal lethality, complete penetrance / MGI
  • embryonic lethality during organogenesis, incomplete penetrance / MGI
  • abnormal ureteric bud tip morphology / MGI

Literature references

  • Impairment of Wnt11 function leads to kidney tubular abnormalities and secondary glomerular cystogenesis.;Nagy Irina I, Xu Qi, Naillat Florence, Ali Nsrein, Miinalainen Ilkka, Samoylenko Anatoly, Vainio Seppo J, ;2016;BMC developmental biology;16;30; 27582005
  • Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric branching during metanephric kidney development.;Majumdar Arindam, Vainio Seppo, Kispert Andreas, McMahon Jill, McMahon Andrew P, ;2003;Development (Cambridge, England);130;3175-85; 12783789

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).